Icon

KRINTAFEL (nda210795)- (EQ 150MG BASE)

TAFENOQUINE SUCCINATE GLAXOSMITHKLINE
EQ 150MG BASE
No No
Expired 2023-Jul-20
None None
None No
KRINTAFEL is an antimalarial indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving chloroquine therapy for acute P. vivax infection.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 150MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.